Baylor Medicine receives multiple recognitions from the American Heart Association
Baylor Medicine, the premier academic medical practice of Baylor College of Medicine, has received the Target: Type 2 Diabetes℠ Gold and Participant recognitions, the Check. Change. Control. Cholesterol™ Gold recognition and the Target: BP™ Gold+ and Silver+ recognitions from the American Heart Association. These awards recognize Baylor Medicine practices and specialties that are dedicated to decreasing the number of people living with diabetes, uncontrolled blood pressure and high cholesterol.
“The 2026 American Heart Association recognitions are a wonderful reflection of the commitment of Baylor Medicine's clinicians and staff to improving the cardiovascular health of our patients through personalized, evidence-based care,” said Dr. Ashwin Viswanathan, interim chief medical officer of Baylor Medicine.
The Target: Type 2 Diabetes℠ recognition acknowledges outpatient practices in their efforts to address type 2 diabetes and cardiovascular disease in their patient populations. The Participant level is for specialties and practices committed to improving diabetes control via practice changes. The Gold level is for specialties and practices that have achieved HbA1c control in patients with diabetes and >70% adherence to cardiovascular measures.
Those awarded the Participant recognition are:
Baylor Medicine Cardiology – Fannin Tower (Texas Medical Center)
Baylor Medicine Cardiology – Sugar Land
Those awarded the Gold recognition are:
Baylor Medicine Atherosclerosis
Baylor Medicine Cardiology
Baylor Medicine Comprehensive Health Clinic
Baylor Medicine Endocrinology
Baylor Medicine Family Medicine – Kirby
Baylor Medicine Family Medicine – Fannin Tower (Texas Medical Center)
Baylor Medicine Family Medicine – River Oaks
Baylor Medicine Geriatrics
Baylor Medicine General Internal Medicine – McNair
Baylor Medicine General Internal Medicine – San Felipe
Baylor Medicine Nephrology
Baylor Medicine Transition Medicine
The Check. Change. Control. Cholesterol™ Gold recognition is for specialties and practices that have achieved >70% appropriate statin therapy use and are committed to lowering cholesterol via practice changes.
Those awarded the Gold recognition are:
Baylor Medicine Atherosclerosis
Baylor Medicine Cardiology – Fannin Tower (Texas Medical Center)
Baylor Medicine Cardiology – McNair
Baylor Medicine Cardiology – Sugar Land
Baylor Medicine Comprehensive Health Clinic
Baylor Medicine Endocrinology
Baylor Medicine Family Medicine – Kirby
Baylor Medicine Family Medicine – Fannin Tower (Texas Medical Center)
Baylor Medicine Family Medicine – River Oaks
Baylor Medicine Geriatrics
Baylor Medicine General Internal Medicine – McNair
Baylor Medicine General Internal Medicine – San Felipe
Baylor Medicine Nephrology
Texas Heart Institute
Target: BP™ is a national initiative to respond to the high prevalence of uncontrolled blood pressure. Silver+ recognition is for practices and specialties that have attested four to six evidence-based criteria in the Measure Accuracy Pillar, the Act Rapidly Pillar and one additional pillar. Gold+ recognition is for practices and specialties that have achieved >70% blood pressure control and attested four to six evidence-based criteria in the Measure Accuracy Pillar, the Act Rapidly Pillar and one additional pillar.
Those awarded the Silver+ recognition are:
Baylor Medicine Endocrinology
Baylor Medicine Geriatrics
Baylor Medicine Nephrology
Texas Heart Institute
Those awarded the Gold+ recognition are:
Baylor Medicine Atherosclerosis
Baylor Medicine Cardiology – Fannin Tower (Texas Medical Center)
Baylor Medicine Cardiology – McNair
Baylor Medicine Cardiology – Sugar Land
Baylor Medicine Comprehensive Health Clinic
Baylor Medicine Family Medicine – Kirby
Baylor Medicine Family Medicine – Fannin Tower (Texas Medical Center)
Baylor Medicine Family Medicine – River Oaks
Baylor Medicine General Internal Medicine – McNair
Baylor Medicine General Internal Medicine – San Felipe
Baylor Medicine Transition Medicine